title: AstraZeneca halts two lung cancer drug trials.
authors.forename: Katherine
authors.initials: K
authors.lastname: Gourd
mesh_terms: D000178:Acrylamides / Q000627:therapeutic use* / Q000633:toxicity; D000814:Aniline Compounds / Q000627:therapeutic use* / Q000633:toxicity; D000911:Antibodies, Monoclonal / Q000627:therapeutic use* / Q000633:toxicity; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use* / Q000633:toxicity; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D004345:Drug Industry; D057239:Early Termination of Clinical Trials; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D007211:Indoles; D011743:Pyrimidines
chemical_list: D000178:Acrylamides; D000814:Aniline Compounds; D000911:Antibodies, Monoclonal; C000613593:durvalumab; C000596361:osimertinib; D007211:Indoles; D011743:Pyrimidines